GeneTex
United States (US)

Apo-SAA recombinant protein

Apo-SAA-recombinant-protein-GTX65234-WB-1_18121409_942.jpg

Cat No. GTX65234

Application WB, ELISA, Functional Assay, Apuri, Blocking
Reactivity Human
Species Human
APPLICATION

Application Note

For most in vitro applications, apo-SAA exerts its biological activity in the concentration range of 10-50 ug/ml.

Calculated MW

11.5 kDa. ( Note )
PROPERTIES

Form

Lyophilized powder

Storage

Reconstitute in 0.1% acetic acid to a concentration of 1. Stored at -20ºC for future use.

Antigen Species

Human

Expression System

E. coli

Purification


Purity was assessed by SDS-PAGE (≥98%) and by HPLC (≥98%).

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Serum amyloid A protein, Amyloid protein A, Amyloid fibril protein AA, MGC111216, SAA, PIG4, TP53I4, SAA1, SAA2

Background

Human apo-SAA is a 104 amino acid polypeptide that circulates primarily in association with high-density lipoproteins (HDL). The level of apo-SAA, normally 1-5 μg/ml in plasma, increases 500-1000 fold within 24 hours of an inflammatory stimulus and, under these conditions, is the most abundant HDL apo-lipoprotein. The human SAA gene codes for a 122 amino acid polypeptide, which contains an 18 amino acid N-terminal signal sequence.
DATA IMAGES
Apo-SAA-recombinant-protein-GTX65234-WB-1_18121409_942.jpg

GTX65234 WB Image

Purity of recombinant Apo-SAA (2 µg) was analyzed by reduced SDS-PAGE electrophoresis.

Package List Price ($)
$ 249